Metraipolis › archive › dc_c8c8aef9ace0

Epidemiological and clinical features of Panton-Valentine Leukocidin positive Staphylococcus aureus bacteremia: A case-control study — Europe PMC PMID:35303019

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35303019
DOI
10.1371/journal.pone.0265476
License (as archived)
CC0-1.0
Archived
2026-10-26T19:59:48.550Z
SHA-256 of the archived text
ea983db26814f73f26c329ffd743c5648dad270d7dbac92f4add143deb8cfc76
Stable URL of this page
https://metraipolis.com/documento/dc_c8c8aef9ace0

How to cite

Epidemiological and clinical features of Panton-Valentine Leukocidin positive Staphylococcus aureus bacteremia: A case-control study — Europe PMC PMID:35303019 — Europe PMC (en), https://europepmc.org/article/MED/35303019 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_c8c8aef9ace0 (Metraipolis archive dc_c8c8aef9ace0, sha256 ea983db26814f73f26c329ffd743c5648dad270d7dbac92f4add143deb8cfc76)
BibTeX
@misc{dcc8c8aef9ace0,
  title = {Epidemiological and clinical features of Panton-Valentine Leukocidin positive Staphylococcus aureus bacteremia: A case-control study — Europe PMC PMID:35303019},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35303019},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_c8c8aef9ace0; sha256 ea983db26814f73f26c329ffd743c5648dad270d7dbac92f4add143deb8cfc76},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35303019. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Panton-Valentine Leukocidin (PVL) toxin in Staphylococcus aureus has been associated with both severe pneumonia and skin and soft tissue infections. However, there are only limited data on how this virulence factor may influence the clinical course or complications of bacteremic S. aureus infections. Methods: Between September 2016 and March 2018, S. aureus isolates from clinical cultures from hospitals in an academic medical center underwent comprehensive genomic sequencing. Four hundred sixty-nine (29%) of 1681 S. aureus sequenced isolates were identified as containing the genes that encode for PVL. Case patients with one or more positive blood cultures for PVL were randomly matched with control patients having positive blood cultures with lukF/lukS-PV negative (PVL strains from a retrospective chart review). Results: 51 case and 56 control patients were analyzed. Case patients were more likely to have a history of injection drug use, while controls more likely to undergo hemodialysis. Isolates from 78.4% of case patients were methicillin resistant as compared to 28.6% from control patients. Case patients had a higher incidence of pneumonia and skin and soft tissue infection and longer duration of fever without differences in length of bacteremia. Clinical cure or expiration was comparable. Conclusions: These results are consistent with prior observations associating the PVL toxin with both community-acquired MRSA strains as well as severe staphylococcal pneumonia. The presence of the PVL toxin does not appear to otherwise influence the natural history of bacteremic S. aureus disease other than in prolonging the duration of fever.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-03-18).
Identificativi: PMID 35303019 · PMCID PMC8932578 · DOI 10.1371/journal.pone.0265476.
Descrittori MeSH principali: Bacteremia; Staphylococcal Infections; Pneumonia, Staphylococcal; Community-Acquired Infections; Soft Tissue Infections; Methicillin-Resistant Staphylococcus aureus.
Pagina: https://europepmc.org/article/MED/35303019 — https://doi.org/10.1371/journal.pone.0265476. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-26T19:47:19.451Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.